Accelr8, Novartis Extend Evaluation Pact

The firms have extended a technology evaluation agreement for Accelr8's BACcel system through Sept. 30, 2011.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories